secwatch.observer — SEC 8-K summary
======================================

Issuer:     Corvus Pharmaceuticals, Inc. (CRVS)
CIK:        0001626971
Form:       8-K
Filed at:   2024-05-01T23:59:59+00:00
Accession:  0001193125-24-127611
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Corvus cuts ATM program ceiling from $90M to $8.2M; nearly all capacity used
----------------------------------------------------------------------------

- Amendment reduces aggregate offering price under Jefferies ATM from $90M to $8.2M.
- Approximately $8.1M of shares sold to date, leaving ~$100,000 remaining availability.
- Program originally entered into on March 28, 2023; amendment dated May 1, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1626971/000119312524127611/0001193125-24-127611-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1626971/000119312524127611/d779751d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-127611

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer